awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q33895113-A2702DBE-A66B-472E-81C3-576289E20A46
Q33895113-A2702DBE-A66B-472E-81C3-576289E20A46
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33895113-A2702DBE-A66B-472E-81C3-576289E20A46
Hepatocellular carcinoma: novel molecular targets in carcinogenesis for future therapies
P2860
Q33895113-A2702DBE-A66B-472E-81C3-576289E20A46
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33895113-A2702DBE-A66B-472E-81C3-576289E20A46
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
3d273e3eec7e973ae2a40b8e31724d339c3eb0ce
P2860
Phase II, open-label study of brivanib as second-line therapy in patients with advanced hepatocellular carcinoma.